Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Part of paid clinical trials in Cherry Hill, New Jersey.
- Sponsor
- MidAtlantic Retina
- Study ID
- NCT01773954
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Intravitreal Aflibercept Injection — DRUGIncreased or decreased time between visits
Study Details
To evaluate the visual outcome and number of injections required during an optical coherence tomography (OCT)-guided treat and extend regimen with intravitreal aflibercept for treatment of subfoveal neovascular age-related macular degeneration (NVAMD).
Key Dates
- Start date
- Feb 28, 2013
- Status verified
- Apr 2018
- Primary completion
- Mar 31, 2016
- Completion
- Mar 31, 2016
Study Design
- Enrollment
- 40 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Intravitreal Aflibercept Injection MorePatient receives treatment at baseline and week 4 visit. The first time extension criteria are met the follow-up interval will be increased by 4 weeks. Each time the extension criteria is met the interval will be extended by 2 weeks to a maximum of 16 weeks. If a patient is being followed at an 8 week interval but fails to meet extension criteria at a particular visit, treatment will be administered as usual and the follow up interval will be reduced to 4 weeks. If patient is being followed at 10-16 week interval but fails to meet extension criteria at a particular visit, treatment will be administered but the follow-up interval will be reduced by 2 week increments.
Primary Outcome Measure
Mean Change in Best-corrected Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score [ Time Frame: Baseline to Week 52 ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mid Atlantic Retina- Cherry Hill | Cherry Hill | New Jersey | 08002 | - |
| Mid Atlantic Retina- Huntingdon Valley | Huntingdon Valley | Pennsylvania | 19006 | - |
| Mid Atlantic Retina- Wills Eye Institute | Philadelphia | Pennsylvania | 19107 | - |
Find similar trials in Cherry Hill, NJ
By condition
By specialty
Related Studies
- High Resolution Retinal ImagingRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationPHASE1 · Recruiting · Astellas Institute for Regenerative Medicine · Phoenix, Arizona
- Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMDRecruiting · VisionCare, Inc. · Loma Linda, California
- A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)PHASE2 · Recruiting · Janssen Research & Development, LLC · Tucson, Arizona